T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 188 participants.

Also called NCT07422831

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 188 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07422831
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT07422831. Randomized; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
Acronym
T2D INSIGHT
Condition
Non Insulin Dependent Diabetes
Intervention (Device)
Periodic, over-the-counter continuous glucose monitoring
Lead sponsor
University of Colorado, Denver (class: other)
Collaborator
American Diabetes Association (class: other)

Record details

Record id
cardio:ct-nct07422831
Content hash
14ab483f064b1dad1c964fdf8b4edfbeecd03748575c0b21a88baeb1813da27b